 Rain Therapeutics Inc. NASDAQ:RAIN Q1 2022 Results Conference Call May 4, 2022 5:00 PM ET Company Participants Bob Yedid - LifeSci Advisors Avanish Vellanki - CEO Robert Doebele - Chief Scientific Officer Richard Bryce - Chief Medical Officer Nelson Cabatuan - SVP, Finance Conference Call Participants Corinne Jenkins - Goldman Sachs Soumit Roy - Jones Trading Carly Kenselaar - Citi Yige Guo - Guggenheim Securities Operator Good afternoon, and welcome to the Rain Therapeutics First Quarter 2022 Earnings Call. Operator Instructions Please note this event is being recorded. 